Last updated: May 4, 2023
Sponsor: Istituto Ortopedico Galeazzi
Overall Status: Active - Recruiting
Phase
N/A
Condition
Osteoarthritis
Treatment
Immuno-nutrition
Clinical Study ID
NCT05372289
ORTHOPACT (PI: M Briguglio)
L4144
Ages > 60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- male and female sex, of all ethnicities, aged over 60
- arthrodesis involving ≥ 6 vertebrae
- American Society of Anesthesiology (ASA) risk: 1, 2, or 3
- Absence of neurological or psychiatric disorders
- Signing of informed consent and consent to collaborate in all study procedures
- Patients who meet the clinical requirements to undergo their first spinal surgery
Exclusion
Exclusion Criteria:
- American Society of Anesthesiology (ASA) risk: 4
- No cervical arthrodesis
- Diagnosis of neurological or psychiatric disorders
- Revisions
- Therapy with other supplements at the time of the first visit 0
- Known allergy or adverse food reactions
- Chronic inflammatory or autoimmune diseases (e.g. rheumatoid arthritis)
- Gastrointestinal disorders
- Conditions that do not allow to undergo surgery
Study Design
Total Participants: 136
Treatment Group(s): 1
Primary Treatment: Immuno-nutrition
Phase:
Study Start date:
March 16, 2022
Estimated Completion Date:
February 29, 2024
Connect with a study center
IRCCS Istituto Ortopedico Galeazzi
Milan,
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.